Efg Asset Management (Americas) Corp. Charles River Laboratories International, Inc. Transaction History

Efg Asset Management (Americas) Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$203.52 - $273.43 $56,782 - $76,286	-279 Reduced 27.11%	750 $203,000
Q4 2023 Feb 01, 2024	SELL	$164.52 - $238.84 $22,374 - $32,482	-136 Reduced 11.67%	1,029 $243,000
Q3 2023 Nov 09, 2023	BUY	$194.44 - $217.61 $14,194 - $15,885	73 Added 6.68%	1,165 $228,000
Q2 2023 Aug 29, 2023	BUY	$183.71 - $210.25 $200,611 - $229,593	1,092 New	1,092 $229,000

699

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.83B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.